Am J Perinatol 2022; 39(13): 1460-1464
DOI: 10.1055/s-0040-1722656
Original Article

Thiol-Disulfide Homeostasis in Neonatal Patients with Urinary Tract Infection

1   Department of Neonatology, Ankara Dr. Sami Ulus Training and Research Hospital, Ankara, Turkey
,
1   Department of Neonatology, Ankara Dr. Sami Ulus Training and Research Hospital, Ankara, Turkey
,
1   Department of Neonatology, Ankara Dr. Sami Ulus Training and Research Hospital, Ankara, Turkey
,
1   Department of Neonatology, Ankara Dr. Sami Ulus Training and Research Hospital, Ankara, Turkey
,
1   Department of Neonatology, Ankara Dr. Sami Ulus Training and Research Hospital, Ankara, Turkey
,
1   Department of Neonatology, Ankara Dr. Sami Ulus Training and Research Hospital, Ankara, Turkey
,
2   Department of Clinical Biochemistry, Faculty of Medicine, Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkey
› Institutsangaben

Abstract

Objective Urinary tract infection (UTI) is a disease that can cause significant complications in the neonatal period. The thiol-disulfide homeostasis is one of the important antioxidant defense mechanisms. The purpose of this study is to show the relationship between UTI and thiol-disulfide homeostasis in newborns.

Study Design In this prospective study, 40 newborns with UTI and 40 healthy controls were included. Thiol-disulfide tests (disulfide, native thiol, and total thiol levels) and septic screening tests were performed before and after antibiotherapy in UTI group. The control group was selected from healthy newborns who applied to the outpatient clinic.

Results The C-reactive protein and interleukin-6 levels were higher, while native thiol and native thiol/total thiol ratio were significantly lower in pretreatment group compared with posttreatment and control group. Also, the levels of disulfide, ischemia modified albumin, disulfide/native thiol ratio, and disulfide/total thiol ratio were higher in pretreatment group compared with posttreatment group.

Conclusion The thiol-disulfide homeostasis is an important indicator of oxidative stress during infections. It is valuable to be detected with small amounts of serum in newborns. These molecules can be used to support the diagnosis of UTI in the newborn. Further studies are needed to define the role of thiol-disulfide homeostasis in the UTI of newborn.

Key Points

  • The thiol-disulfide homeostasis can be an important indicator of oxidative stress during infections such as UTI.

  • The thiol-disulfide homeostasis of newborn is valuable to be detected with small amounts of serum in neonatal period.

  • Laboratory tests such as white blood cell count, erythrocyte sedimentation rate, and C-reactive protein are not significantly different in UTIs.

Note

The study was approved by Clinical Research Ethics Committee on January 22, 2020 with the report number 2012-KAEK-15/2007.




Publikationsverlauf

Eingereicht: 13. November 2020

Angenommen: 17. Dezember 2020

Artikel online veröffentlicht:
17. Januar 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Zorc JJ, Levine DA, Platt SL. et al; Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics 2005; 116 (03) 644-648
  • 2 Ismaili K, Lolin K, Damry N, Alexander M, Lepage P, Hall M. Febrile urinary tract infections in 0- to 3-month-old infants: a prospective follow-up study. J Pediatr 2011; 158 (01) 91-94
  • 3 Bonadio W, Maida G. Urinary tract infection in outpatient febrile infants younger than 30 days of age: a 10-year evaluation. Pediatr Infect Dis J 2014; 33 (04) 342-344
  • 4 Samayam P, Ravi Chander B. Study of urinary tract infection and bacteriuria in neonatal sepsis. Indian J Pediatr 2012; 79 (08) 1033-1036
  • 5 Riskin A, Toropine A, Bader D, Hemo M, Srugo I, Kugelman A. Is it justified to include urine cultures in early (< 72 hours) neonatal sepsis evaluations of term and late preterm infants?. Am J Perinatol 2013; 30 (06) 499-504
  • 6 Didier C, Streicher MP, Chognot D. et al. Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics. Eur J Pediatr 2012; 171 (04) 681-687
  • 7 Foglia EE, Lorch SA. Clinical predictors of urinary tract infection in the neonatal intensive care unit. J Neonatal Perinatal Med 2012; 5 (04) 327-333
  • 8 Shakir SM, Goldbeck JM, Robison D, Eckerd AM, Chavez-Bueno S. Genotypic and phenotypic characterization of invasive neonatal Escherichia coli clinical isolates. Am J Perinatol 2014; 31 (11) 975-982
  • 9 Kundi H, Ates I, Kiziltunc E. et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulfide homeostasis. Am J Emerg Med 2015; 33 (11) 1567-1571
  • 10 Ates I, Kaplan M, Yuksel M. et al. Determination of thiol/disulfide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016; 51 (01) 47-51
  • 11 Köseoğlu H, Alışık M, Başaran M. et al. Dynamic thiol/disulfide homeostasis in acute pancreatitis. Turk J Gastroenterol 2018; 29 (03) 348-353
  • 12 Erel O, Neselioglu S. A novel and automated assay for thiol/disulfide homeostasis. Clin Biochem 2014; 47 (18) 326-332
  • 13 Yamaguchi J, Nagase M, Yamamoto Y. et al. Increased oxidative stress and renal injury in patients with sepsis. J Clin Biochem Nutr 2018; 63 (02) 137-143
  • 14 American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 1999; 103 (4 Pt 1): 843-852
  • 15 Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - review and clinical implications. Clin Chem Lab Med 2011; 49 (02) 177-184
  • 16 Erdem SS, Yerlikaya FH, Çiçekler H, Gül M. Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis. Clin Chem Lab Med 2012; 50 (08) 1417-1421
  • 17 Zurawska-Płaksej E, Grzebyk E, Marciniak D, Szymańska-Chabowska A, Piwowar A. Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome. J Endocrinol Invest 2014; 37 (09) 819-827
  • 18 Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000; 19 (04) 311-315
  • 19 Temel MT, Demiryürek S, Temel L. et al. Dynamic thiol/disulfide homeostasis in children with community-acquired pneumonia. Pediatr Int (Roma) 2019; 61 (03) 252-257
  • 20 Yildiz H. Thiol/disulfide homeostasis in intensive care unit patients with sepsis and septic shock. Turk J Med Sci 2020; 50 (04) 811-816
  • 21 Kolgelier S, Ergin M, Demir LS. et al. Impaired thiol-disulfide balance in acute brucellosis. Jpn J Infect Dis 2017; 70 (03) 258-262
  • 22 Jackson EC. Urinary tract infections in children: knowledge updates and a salute to the future. Pediatr Rev 2015; 36 (04) 153-164 , quiz 165–166
  • 23 Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010; 48 (06) 749-762
  • 24 Ayar G, Sahin S, Men Atmaca Y, Uysal Yazici M, Neselioglu S, Erel O. Thiol-disulfide homeostasis is an oxidative stress indicator in critically ill children with sepsis. Arch Argent Pediatr 2019; 117 (03) 143-148
  • 25 Aydogan S, Akduman H, Dilli D. et al. The role of thiol-disulfide homeostasis in neonatal sepsis. J Matern Fetal Neonatal Med 2019; 1-7
  • 26 Kumar S, Gupta E, Kaushik S, Kumar Srivastava V, Mehta SK, Jyoti A. Evaluation of oxidative stress and antioxidant status: correlation with the severity of sepsis. Scand J Immunol 2018; 87 (04) e12653
  • 27 Kara SS, Erel O, Demirdag TB. et al. Alteration of thiol-disulfide homeostasis in acute tonsillopharyngitis. Redox Rep 2017; 22 (05) 205-209